107 Results for "

complement inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (107)

107 Results for "complement inhibitors" in MCE Product Catalog:

Cat. No.: HY-P3502A
Synonyms: RA101495 TFA; RA3193 TFA
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Zilucoplan TFA (RA101495), a 15-amino acid macrocyclic peptide, is a potent complement component 5 (C5) inhibitor. Zilucoplan TFA can be used in research of immune-mediated necrotising myopathy (IMNM) .
loading...
    loading...
Cat. No.: HY-153098
ARC186 (sodium) is an unconjugated 40KDa PEG aptamer with a sequence identical to HY-147080 Avacincaptad pegol (ARC1905) sodium. ARC1905 is highly potent complement inhibitors that function by blocking the convertase-catalyzed activation of C5.
loading...
    loading...
Cat. No.: HY-P3204A
Synonyms: AL-78898A TFA
Target:  

Complement System

Research Areas:  

Metabolic Disease

POT-4 TFA (AL-78898A TFA), a Compstatin derivative, is a potent inhibitor of complement factor C3 activation. POT-4 TFA can be used for age-related macular degeneration research .
loading...
    loading...
Cat. No.: HY-P99886
CAS No.: 219685-93-5
Synonyms: h5G1. 1-SC
Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction .
loading...
    loading...
Cat. No.: HY-P10274
CAS No.: 3037805-45-8
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

CM05 is a bromo-fatty acid. CM05 can be used to modify ornithodoros moubata complement inhibitor (OmCI) and extend the half-life of OmCI .
loading...
    loading...
Cat. No.: HY-W049802
CAS No.: 918531-01-8
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

N-((Allyloxy)carbonyl)-N-methyl-L-alanine is a Alanine derivative. N-((Allyloxy)carbonyl)-N-methyl-L-alanine can be used for the synthesis of inhibitors of complement factor D. Complement factor D inhibitors can be used in the research of immune system related disease .
loading...
    loading...
Cat. No.: HY-174913
CAS No.: 1644670-23-4
Factor B-IN-5 is an orally active complement factor B (CFB) inhibitor. Factor B-IN-5 alleviates kidney damage in diabetes nephropathy by inhibiting the over activation of complement system and improving mitochondrial function. Factor B-IN-5 can improve renal tubulointerstitial inflammation and fibrosis. Factor B-IN-5 can be used for research on diabetic nephropathy .
loading...
    loading...
Cat. No.: HY-178284
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Factor B-IN-7 (Compound (I)) is a selective Factor B inhibitor. Factor B-IN-7 inhibits Factor B-C3b interaction to suppress complement hyperactivation. Factor B-IN-7 is promising for research of paroxysmal nocturnal hemoglobinuria (PNH), C3 glomerulopathy, and age-related macular degeneration (AMD) associated with complement-mediated diseases .
loading...
    loading...
Cat. No.: HY-P1398A
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Compstatin control peptide TFA is a negative control of Compstatin (HY-P1036). Compstatin is a potent complement system C3 inhibitor .
loading...
    loading...
Cat. No.: HY-W587516
CAS No.: 10040-44-5
Research Areas:  

Cardiovascular Disease

Bisphenol A bissulfate disodium is a metabolite of Bisphenol A (HY-18260) . Bisphenol A bissulfate disodium (compound 7) show complement-inhibiting activity with an IC50 of 247 μM .
loading...
    loading...
Cat. No.: HY-E70390
Synonyms: masp-2, c1 esterase, c1-esterase
Target:  

Wnt

C1s Enzyme is a subunit of the complement C1 complex, which activates the complement as a serine protease. C1s Enzyme cleaves LRP5 and LRP6, and thus activates the Wnt/β-Catenin signaling pathway. C1s Enzyme promotes the macrophage M2 polarization and inhibits M1 polarization. C1s Enzyme enhances efferocytosis, exhibits anti-inflammatory activity .
loading...
    loading...
Cat. No.: HY-147605
CAS No.: 2760669-74-5
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Factor B-IN-3 (Example 3 target compound) is a potent complement factor B inhibitor. Factor B-IN-3 can be used for the research of diseases related to inflammation and immunity .
loading...
    loading...
Cat. No.: HY-147606
CAS No.: 2760669-84-7
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Factor B-IN-4 (Example 13 target compound) is a potent complement factor B inhibitor, with an IC50 of 1 μM. Factor B-IN-4 can be used for the research of diseases related to inflammation and immunity .
loading...
    loading...
Cat. No.: HY-147607
CAS No.: 2797066-85-2
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Factor B-IN-5 (Example 5 target compound) is a potent complement factor B inhibitor, with an IC50 of 1.2 μM. Factor B-IN-5 can be used for the research of diseases related to inflammation and immunity .
loading...
    loading...
Cat. No.: HY-153098A
Purity:  94.13%
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

ARC186 (sodium) is an unconjugated 40KDa PEG aptamer with a sequence identical to HY-147080 Avacincaptad pegol (ARC1905) sodium. ARC1905 is highly potent complement inhibitors that function by blocking the convertase-catalyzed activation of C5.
loading...
    loading...
Cat. No.: HY-147604
CAS No.: 2760669-72-3
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Factor B-IN-2 (Example 1 target compound) is a potent complement factor B inhibitor, with an IC50 of 1.5 μM. Factor B-IN-2 can be used for the research of diseases related to inflammation and immunity .
loading...
    loading...
Cat. No.: HY-153785
Purity:  92.50%
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

NH2-C6-ARC186 sodium is a modified ARC186 (HY-153098) with NH2-C6 that can be coupled to other peptides or molecules. ARC186 is a aptamer and a highly potent complement inhibitor that function by blocking the convertase-catalyzed activation of C5 .
loading...
    loading...
Cat. No.: HY-P991585

Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

MORAb-028 is a humanized IgG1 monoclonal antibody inhibitor targeting GD2. MORAb-028 has a potent antitumor activity and kills GD2-expressing target cells via complement-mediated cytotoxicity (CDC). MORAb-028 significantly inhibits tumor growth in EL-4-luc xenograft mice model. MORAb-028 can be used for melanoma cancer research .
loading...
    loading...
Cat. No.: HY-P990753
CAS No.: 2763342-87-4
Synonyms: CAN-106

Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Omoprubart is an anti-C5 complement recombinant humanized monoclonal antibody. Omolubat can prevent C5 from cleaving into C5a and C5b, thereby inhibiting the formation and activation of the C5b-dependent membrane attack complex (MAC) on the surface of susceptible cells, leading to cell lysis (destruction). Omoprubart can be used for the study of paroxysmal nocturnal hemoglobinuria (PNH).
loading...
    loading...
Cat. No.: HY-P5509
CAS No.: 230968-98-6
Target:  

Inhibitory Antibodies

Research Areas:  

Others

C5aR1 antagonist peptide is a biological active peptide. (This linear peptide is derived from the C-terminus of the chemokine, complement fragment 5 anaphylatoxin (C5a). This peptide functions to inhibit C5a binding and function at human and rat C5a receptors. C5a is crucial to triggering cellular immune responses and its overexpression is involved in arthritis, Alzheimer’s disease, cystic fibrosis, systemic lupus erythematosus, and other immunoinflammatory diseases.)
loading...
    loading...